| P2093 | author name string | W Weimar | |
| | C C Baan | |
| | I C van Riemsdijk-Overbeeke | |
| | J M N IJzermans | |
| | M J A M Boelaars-van Haperen | |
| P2860 | cites work | The Jak-STAT pathway | Q33899139 |
| | Interleukin 2 and its receptors: recent advances and new immunological functions | Q34063626 |
| | Role and regulation of interleukin (IL)-2 receptor alpha and beta chains in IL-2-driven B-cell growth | Q36961056 |
| | Intracellular signaling consequences of anti-IL-2Ralpha blockade by daclizumab | Q40818619 |
| | Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? | Q41360833 |
| | A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation | Q46752311 |
| | Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group | Q47887130 |
| | Signaling from the IL-2 receptor to the nucleus | Q47992419 |
| | The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. | Q50335906 |
| | Control of homeostasis of CD8+ memory T cells by opposing cytokines. | Q52027383 |
| | Limiting dilution assays. Experimental design and statistical analysis. | Q52603254 |
| | Adjusting immunosuppression to the identification of T-cell activating mediators in rejecting transplants: a novel approach to rejection diagnosis and treatment | Q56907631 |
| | T cells are just dying to accept grafts | Q63408399 |
| | The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities | Q70361166 |
| | Intragraft IL-15 transcripts are increased in human renal allograft rejection | Q71469425 |
| | Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events | Q73370304 |
| | Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody | Q73502584 |
| | Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection | Q73518971 |
| | IL-7 and IL-15 bypass the immunosuppressive action of anti-CD25 monoclonal antibodies | Q73936165 |
| | Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group | Q74038855 |
| | Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group | Q74602309 |
| | Screening for basiliximab exposure-response relationships in renal allotransplantation | Q74613772 |
| | Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation | Q77312399 |
| P433 | issue | 1 | |
| P304 | page(s) | 81-87 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Inhibition of the IL-15 pathway in anti-CD25 mAb treated renal allograft recipients | |
| P478 | volume | 10 | |